Hematologia e bioquímica sérica de equinos de concurso completo de equitação em treinamento

Avaliaram-se a hematologia e a bioquímica sérica em equinos de concurso completo de equitação (CCE) em treinamento durante testes de esforço incremental em esteira ergométrica de alta velocidade. Foram utilizados 16 equinos em delineamento experimental inteiramente ao acaso com quatro tratamentos e quatro repetições em esquema de parcelas subdivididas, utilizando-se como fontes de variação nos tratamentos a idade e o histórico de treinamento em CCE. As parcelas foram constituídas pelos testes incrementais realizados nas fases inicial e final do treinamento. As subparcelas foram representadas pelos tempos de avaliação e coletas. Os equinos do grupo experimental novos iniciantes apresentaram valor médio do hematócrito de 43,24%, sendo inferior ao hematócrito do grupo adultos iniciantes, 45,63%, novos experientes, 46,39%, e competidores, 47,74%. Houve diferença (P<0,05) entre os testes físicos realizados nas fases inicial e final do treinamento, com redução na concentração plasmática de glicose, de 112 para 98,88mg/dL, nas concentrações séricas de creatinina, de 1,41 para 1,29mg/dL, e de proteínas totais, de 6,52 para 6,38g/dL, na contagem de monócitos, de 0,54 para 0,48 10³/mm³, e com aumento na concentração plasmática de lactato, de 3,31 para 3,79mmol/L, na concentração sérica de ácido úrico, de 1,44 para 1,77mg/dL, no hematócrito, de 44,19 para 46,90%, na concentração de hemoglobina, de 14,33 para 15,10g/dL, e na contagem de leucócitos totais, de 9,26 para 9,61 10³/mm³. O treinamento dos equinos de CCE aumentou o condicionamento físico dos equinos, com maior capacidade de metabolização do lactato após o exercício e aumento nos valores basais do hematócrito e da concentração de hemoglobina

Hematologia e bioquímica sérica de equinos de concurso completo de equitação em treinamento Hematology and serum biochemistry of event horses in training

Avaliaram-se a hematologia e a bioquímica sérica em equinos de concurso completo de equitação (CCE) em treinamento durante testes de esforço incremental em esteira ergométrica de alta velocidade. Foram utilizados 16 equinos em delineamento experimental inteiramente ao acaso com quatro tratamentos e quatro repetições em esquema de parcelas subdivididas, utilizando-se como fontes de variação nos tratamentos a idade e o histórico de treinamento em CCE. As parcelas foram constituídas pelos testes incrementais realizados nas fases inicial e final do treinamento. As subparcelas foram representadas pelos tempos de avaliação e coletas. Os equinos do grupo experimental novos iniciantes apresentaram valor médio do hematócrito de 43,24%, sendo inferior ao hematócrito do grupo adultos iniciantes, 45,63%, novos experientes, 46,39%, e competidores, 47,74%. Houve diferença (P<0,05) entre os testes físicos realizados nas fases inicial e final do treinamento, com redução na concentração plasmática de glicose, de 112 para 98,88mg/dL, nas concentrações séricas de creatinina, de 1,41 para 1,29mg/dL, e de proteínas totais, de 6,52 para 6,38g/dL, na contagem de monócitos, de 0,54 para 0,48 10³/mm³, e com aumento na concentração plasmática de lactato, de 3,31 para 3,79mmol/L, na concentração sérica de ácido úrico, de 1,44 para 1,77mg/dL, no hematócrito, de 44,19 para 46,90%, na concentração de hemoglobina, de 14,33 para 15,10g/dL, e na contagem de leucócitos totais, de 9,26 para 9,61 10³/mm³. O treinamento dos equinos de CCE aumentou o condicionamento físico dos equinos, com maior capacidade de metabolização do lactato após o exercício e aumento nos valores basais do hematócrito e da concentração de hemoglobina.<br>Was evaluated the hematology and serum biochemistry in event horses (CCE) in training during incremental treadmill tests. Sixteen horses were used in a completely randomized design with four treatments and four repetitions in subdivided parcels, using age and previous history of training in events as sources of treatment variation. The parcels constituted of incremental treadmill tests performed at the beginning and end of training. The subparcels were represented by the time of evaluation and collection of samples. The equines of new beginners group had mean hematocrit value of 43.24%, being lower than the hematocrit of adult beginners group, 45.63%, new experienced group, 46.39%, and competitors group, 47.74%. There were differences (P<0.05) between the tests performed at the beginning and end of training, with reduction in glucose plasma concentration, from 112 to 98,88mg/dL, in seric concentration of creatinine, 1.41 to 1.29mg/dL, and total protein, 6.52 to 6.38 g/dL, in monocyte count, 0.54 to 0.48 10³/mm³, and an increase of lactate plasma concentration, from 3.31 to 3.79mmol/L, in seric concentration of uric acid, 44 to 1.77mg/dL, in hematocrit, 44.19 to 46.90%, in hemoglobin concentration, 14.33 to 15.10 g/dL, and blood cell count, 9.26 to 9.61 10³/mm³. The training of event horses improves physical performance of horses, with increased capacity of lactate metabolism after exercise and increased basal hematocrit and hemoglobin concentration

Dehydrocrotonin And Its β-cyclodextrin Complex: Cytotoxicity In V79 Fibroblasts And Rat Cultured Hepatocytes

Trans-dehydrocrotonin has antiulcerogenic and antitumor activities. A complex of β-cyclodextrin with dehydrocrotonin was developed to improve the delivery of dehydrocrotonin. Complex in solid state was evaluated using X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and scanning electron microscopy (SEM). X-ray diffraction and scanning electron microscopy studies showed that dehydrocrotonin exists in a semicrystalline state in the complexed form with β-cyclodextrin. Differential scanning calorimetry studies showed the existence of a complex of dehydrocrotonin with β-cyclodextrin. The thermal gravimetric analysis studies confirmed the differential scanning calorimetry results of the complex. Free dehydrocrotonin and the dehydrocrotonin/β-cyclodextrin inclusion complex were assayed in freshly isolated rat hepatocytes and in V79 cells. Cytotoxicity was determined using nucleic acid content, methylthiazoletetrazolium (MTT) reduction and neutral red uptake assays. In all assays, there was a large reduction (3.5-16.1-fold) in the cytotoxicity of dehydrocrotonin in hepatocytes when complexed with β-cyclodextrin, whereas for V79 cells the decrease in cytotoxicity was 1.7- and 1.87-fold for MTT reduction and nucleic acid content assays, respectively. The lower cytotoxicity of the dehydrocrotonin/β-cyclodextrin complex compared to free dehydrocrotonin in rat hepatocytes and V79 cells suggests that such a complex may be useful for the administration of dehydrocrotonin in vivo. © 2005 Elsevier B.V. All rights reserved.5101-21724Agner, A.R., MacIel, M.A., Pinto, A.C., Colus, I.M., Antigenotoxicity of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara (2001) Planta Med., 67, pp. 815-819Anazetti, M.C., Melo, P.S., De Azevedo, M.B.M., De Carvalho, C.A., Durán, N., Haun, M., β-Cyclodextrin complexed with dehydrocrotonin induces apoptosis in HL60 cells as seen by flow cytometry (2004) XII Congress of the Brazilian Society for Cell Biology and IX Ibero-American Congress of Cell Biology. Brazil: Campinas, I-012Bianchi, V., Fortunati, E., Cellular effects of an anionic surfactant detected in V79 fibroblasts by different cytotoxicity tests (1990) Toxicol. in Vitro, 4, pp. 9-16Bibby, D., Davies, N.M., Tucker, I.G., Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems (2000) Int. J. Pharm., 197, pp. 1-11Borefreund, E., Puerner, J.A., A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR 90) (1984) J. Tissue Cult. Methods, 9, pp. 7-9Cingi, M.R., De Angelis, I., Fortunati, E., Reggiani, D., Bianchi, V., Tiozzo, R., Zucco, F., Choice and standardization of test protocols in cytotoxicology: A multicentre approach (1991) Toxicol. in Vitro, 5, pp. 119-125De Azevedo, M.B.M., Alderete, J.B., Lino, A.C.S., Loh, W., Faljoni-Alario, A., Durán, N., Violacein/β-cyclodextrin inclusion complex formation studied by measurements of diffusion coefficient and circular dichroism (2000) J. Ind. Phenom. Mol. Recognit. Chem., 37, pp. 67-74De Azevedo, M.B.M., Zullo, M.A.T., Alderete, J.B., De Azevedo, M.M.M., Durán, N., Characterization and properties of the inclusion complex of 24-epibrassinolide with β-cyclodextrin (2002) Plant Growth Regul., 37, pp. 233-240Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability (1986) J. Immunol. Methods, 89, pp. 271-277Griffiths, D.W., Bender, M.L., Orientational catalysis by cyclohexaamylose (1973) J. Am. Chem. Soc., 95, pp. 1679-1680Grynberg, N.F., Echevarria, A., Lima, J.E., Pamplona, S.S.R., Pinto, A.C., MacIel, M.A., Anti-tumour activity of two 19-nor-clerodane diterpenes, trans-dehydrocrotonin and trans-crotonin, from Croton cajucara (1999) Planta Med., 65, pp. 687-689Guguen-Guillouzo, C., Guillouzo, A., Methods for preparation of adult and fetal hepatocytes (1986) Research in Isolated and Cultured Hepatocytes, pp. 1-12. , A. Guillouzo C. Guguen-Guillouzo Les Editions John Libbey Eurotext London, UKHirayama, F., Uekama, K., Cyclodextrin-based controlled drug release system (1999) Adv. Drug Deliv. Rev., 36, pp. 125-141Hiruma-Lima, C.A., Spadari-Bratfisch, R.C., Kassisse, D.M., Souza-Brito, A.R.M., Antiulcerogenic mechanisms of dehydrocrotonin, a diterpene lactone obtained from Croton cajucara (1999) Planta Med., 65, pp. 325-330Katzer, A., Marquardt, H., Westendorf, J., Wening, J.V., Von F., G., Polyetheretherketone-cytotoxicity and mutagenicity in vitro (2002) Biomaterials, 23, pp. 1749-1759Loftsson, T., Pharmaceutical applications of β-cyclodextrins (1999) Pharm. Technol. Europe, 11, pp. 20-32Melo, P.S., Durán, N., Haun, M., Derivatives of dehydrocrotonin, a diterpene lactone isolated from Croton cajucara: Cytotoxicity in rat cultured hepatocytes and in V79 cells (2002) Human Exp. Toxicol., 21, pp. 281-288Mura, P., Faucci, M.T., Parrini, P.L., Furlanetto, S., Pinzauti, S., Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems (1999) Int. J. Pharm., 179, pp. 117-128Paillard, F., Finot, F., Mouche, I., Prenez, A., Vericat, J.A., Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities (1999) Toxicol. in Vitro, 13, pp. 693-700Rajewski, R.A., Stella, V.J., Pharmaceutical application of cyclodextrins. 2. In vivo drug delivery (1996) J. Pharm. Sci., 85, pp. 1142-1169Ren, X., Xue, Y., Liu, J., Zhang, K., Zheng, J., Luo, G., Guo, C., Shen, J., A novel cyclodextrin-derived tellurium compound with glutathione peroxidase (2002) ChemBioChem, 3, pp. 363-365Rodriguez, J.A., Haun, M., Cytotoxicity of trans-dehydrocrotonin from Croton cajucara on V79 cells and rat hepatocytes (1999) Planta Med., 65, pp. 522-526Souza-Brito, A.R.M., Rodriguez, J.A., Hiruma-Lima, C.A., Haun, M., Nunes, D.S., Antiulcerogenic activity of trans-dehydrocrotonin from Croton cajucara (1998) Planta Med., 64, pp. 126-129Stella, V.J., Rajewski, R.A., Cyclodextrins: Their future in drug formulation and delivery (1997) Pharm. Res., 14, pp. 556-567Szejtli, J., (1988) Cyclodextrin Technology, , Kluwer Academic Dordrecht, NLSzejtli, J., Introduction and general overview of cyclodextrin chemistry (1998) Chem. Rev., 98, pp. 1743-1754Szente, L., Szejtli, J., Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development (1999) Adv. Drug Deliv. Rev., 36, pp. 17-28Thompson, D.O., Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals (1997) Crit. Rev. Ther. Drug Carr. Syst., 14, pp. 1-104Zhao, Q., Temsamani, J., Iadarola, P.L., Agrawal, S., Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs (1996) Biochem. Pharmacol., 52, pp. 1537-154

Effects of growth hormone on in situ culture of bovine preantral follicles are dose dependent

The objective of this study was to evaluate different concentrations of growth hormone (GH) on the development of bovine preantral follicles cultured included in the ovarian tissue (in situ) on the rates of morphologically normal, viable, primordial and developing follicles, as well as the oocyte and follicle diameter and ultrastructural analysis. Ovarian fragments collected from cows with no cross‐breeds defined were cultured in situ for 1 and 7 days in minimal essential medium (α‐MEM+) supplemented with different concentrations of recombinant human GH (0, 10, 25, 50 ng/ml). The ovarian fragments non‐cultured (control) and cultured were processed for classic histology, mechanical isolation and electron transmission microscopy (MET). The parameters underwent anova (Tukey′s and Dunnett′s tests) and chi‐square test (χ2). After 7 days of culture, the treatment with 50 ng/ml GH showed no differences with fresh control (p > 0.05) and had greater effectiveness than in the 0, 10 and 25 ng/ml GH concentrations of the morphologically normal follicles. Regarding the primordial follicles, a reduction was observed in the 50 ng/ml GH concentration concomitant with the significant increase in developing follicles, differing from both the fresh control and the other GH concentrations tested. In addition, 50 ng/ml GH showed a larger follicle and oocyte diameter when compared to the other treatments cultured. Similar structures were ultrastructurally observed in the control group, 50 ng/ml GH. Follicles cultured in 10 ng/ml GH showed nuclear invagination, vacuoles and lesioned basal membrane. Hence, it is concluded that 50 ng/ml GH is the most effective concentration for the development of preantral follicles cultured in situ

Effects of IGF‐1 on In vitro culture of bovine preantral follicles are dose‐dependent

This study aimed at assessing the effect of different concentrations of the growth factor similar to insulin 1 (IGF‐1) in the development, survival and ultrastructure of the bovine preantral follicles cultured in situ. Fragments of bovine ovarian cortical tissue were cultured during 1 and 7 days in 1 ml of α‐MEM+, supplemented with different concentrations of human recombinant IGF‐1 (0, 30, 70 and 100 ng/ml), in an incubator at 37°C and 5% of CO2 in 24‐well plates with total replacement of the medium every 2 days. Non‐cultured ovarian fragments (control) and ovarian fragments cultured during 1 and 7 days were processed for classic histology, mechanical isolation and electron transmission microscopy (ETM). Parameters such as normality, viability, activation, development, diameter and ultrastructure were evaluated. All statistical analyses were carried out using sas Version 9.2. The results showed that the percentage of follicles morphologically normal in the IGF‐1 30 ng/ml treatment was similar to the fresh control (p > 0.05) both on the day 1 and on the day 7 of in vitro culture. In the viability analysis, the cultured treatments maintained the percentage of viable follicles during the entire culture period (p > 0.05). After 7 days of culture, the IGF‐1 30 ng/ml treatment showed higher percentages of developing follicles (48.33%) than those of the fresh control (22.22%) and the cultured treatments (p < 0.05). Also, after 7 days of culture, IGF‐1 30 ng/ml presented a higher follicular diameter when compared to the control and other concentrations of IGF‐1 tested. Ultrastructurally, the non‐cultured control and IGF‐1 30 ng/ml, after 7 days of culture, showed conserved oocytes, nuclei and organelles. Hence, it is concluded that IGF‐1 30 ng/ml was the most efficient concentration for the development of bovine preantral follicles cultured in vitro

Complete genome sequences of corynebacterium pseudotuberculosis strains 3/99-5 and 42/02-A, isolated from sheep in Scotland and Australia, respectively

Here, we report the whole-genome sequences of two ovine-pathogenic Corynebacterium pseudotuberculosis isolates: strain 3/99-5, which represents the first C. pseudotuberculosis genome originating from the United Kingdom, and 42/02-A, the second from Australia. These genome sequences will contribute to the objective of determining the global pan-genome of this bacterium